Navigation Links
DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor

(PRWEB) December 12, 2014

The DNA Microarray market market was valued at $1,253 million in 2013, and is expected to grow at a CAGR of 15.2% from 2014 to 2019.

Browse through the TOC of the DNA Microarray for an in-depth analysis of the industry trends and segments, with help of various tables and figures.

The global DNA Microarray market consists of instrument, consumables, and services, where the consumables market contributed the maximum share for approximately 63% in 2013 among all product segments. The major factors fueling the global DNA Microarray market are emerging technologies, declining average selling prices of instruments and services, and a gradual shift towards the outsourced services market. The global DNA Microarray market was highly dependent on government funding. Leading market players are yet striving to diversify their customer base to combat unexpected fluctuations in government investments.

Early buyers will receive 10% customization on this report.

The report segments DNA Microarray market on the basis of types, products, applications, and geography. The market is further segmented and forecast on the basis of the major regions, such as the North America, Europe, Asia-Pacific, and Rest of the World. The North American market was valued at $423.2 million in 2013, and is the largest regional contributor to the global DNA Microarray market. Also, high growth is expected from the Asian markets, especially in China, India, South Korea, and Singapore due to increasing government investments on biotechnology. Furthermore, China and India being the most populous countries provides the largest base for clinical trials and drug discovery which in turn triggers the DNA microarray market in the region.

Speak to Analyst @

In addition, the report presents a competitive landscape and company profiles of the key players in the market. Affymetrix, Inc. dominates the market due to its increased number of patents, first-to-market presence, and many commercial partnerships. The other key players in this market include Agilent Technologies Pvt. Ltd., Perkin Elmer, Inc., Origene Technologies, Inc., Genomic Solutions, Inc., QIAGEN, Illumina, Inc., Applied microarrays, Inc., Roche Nimbelgen, Inc.; and Sequenom.

Related Reports:

North American DNA Microarray Market

North America accounts for the highest market share of the DNA microarray market in 2013. The market value was pegged at $423.2 million in 2013 and is expected to grow at a CAGR of 11.0% from 2014 to 2019. Factors such as increased focus on personalized medicine rise in diagnostic rates of cancer cases, and technical advances are largely responsible for fuelling the growth of this market.
The key players of the market covered in the report are Illumina, Agilent Technologies, Roche Diagnostics, Sequenom, Inc., Bio-rad Laboratories, Oxford Gene Technology.

European DNA Microarray Market

Europe accounted for 27% market share of the DNA microarray market globally in 2013. The market value was pegged at $337.5 million in 2013 and is expected to grow at a CAGR of 16.2% from 2014 to 2019.
The report provides an extensive competitive landscaping of companies operating in this market. The key players of the market covered in the report are Illumina, Agilent Technologies, Roche Diagnostics, Sequenom, Inc., Bio-rad Laboratories, Oxford Gene Technology.

About MicroMarket Monitor:

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: sales(at)micromarketmonitor(dot)com
Connect with us on LinkedIn at

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray
2. Global Biochips and Microarrays 2013 Market Report
3. Ingenuity Systems and Affymetrix Partner to Eliminate Microarray Expression Analysis Bottleneck
4. Microarray Markets - 2013 Report Examines Companies that are Actively Developing and Marketing Microarray Instrumentation or Microarray Biochips
5. Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies)
6. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
7. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
8. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
9. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
10. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
11. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
Post Your Comments:
(Date:10/12/2017)... SARASOTA, FL (PRWEB) , ... ... ... Inc. (RPS®) today announces publication of a United States multicenter, prospective clinical ... single use, disposable, point-of-care diagnostic test capable of identifying clinically significant acute ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
Breaking Biology Technology:
(Date:6/23/2017)... N.Y. , June 23, 2017  IBM (NYSE: ... dairy research, today announced a new collaboration using next-generation ... chances that the global milk supply is impacted by ... Cornell University has become the newest academic institution to ... a food safety initiative that includes IBM Research, Mars, ...
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
(Date:4/18/2017)... Inc., a global expert in SoC-based imaging and computing solutions, has ... features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® ... be showcased during the upcoming Medtec Japan at Tokyo Big Sight ... Las Vegas Convention Center April 24-27. ... Click here for an image of the ...
Breaking Biology News(10 mins):